Contents tagged with Donanemab
-
Donanemab in Early Symptomatic Alzheimer Disease
https://www.nejm.org/doi/full/10.1056/NEJMoa2100708 more
-
Donanemab: New Alzheimer’s drug slows cognitive decline by 35%, trial results show
https://www.msn.com/en-au/health/medical/new-alzheimer-s-drug-slows-cognitive-decline-by-35-trial-results-show/ar-AA1aGQ0p